CJC-1295 with DAC 2MG

Product overview

CJC-1295 with DAC 2MG is a synthetic GHRH-analogue research material containing a Drug Affinity Complex. It is supplied as white to off-white lyophilised powder in a 2mg catalogue presentation (SKU CD2).

CJC-1295 with DAC was designed to associate with albumin, a blood protein, so researchers could study longer exposure. Research has examined GHRH-receptor activity, how the molecule moves through a system and GH/IGF-related biomarkers.

What researchers study

• How the GHRH receptor responds
• Albumin binding and longer-exposure design
• Growth-hormone and IGF-related biomarkers
• Laboratory methods for tracking the peptide over time

Evidence and limitations

Human research is small and early stage. It does not establish how this independently supplied material performs.

Storage and laboratory handling

Before preparing a solution: Keep the vial sealed, dry and protected from light. Follow the product label, safety data and batch documentation for the required storage temperature.

After preparing a solution: No product-specific shelf life or universal compatibility has been established. The laboratory must validate the solvent, concentration, container, temperature and hold time for its method.

Handle only in an appropriately equipped laboratory using suitable personal protective equipment and local disposal procedures.

Sources

• Cayman Chemical: CJC-1295 with DAC trifluoroacetate storage reference
• CJC-1295 pharmacokinetic and pharmacodynamic study (PMID 16352683)
• ClinicalTrials.gov CJC-1295 study record
• CJC-1295 with DAC 5MG

Scientific sources last reviewed: 23 August 2026.

Research use

For laboratory research use only. Not for human or veterinary use. Purchasers are responsible for lawful handling, storage and disposal in accordance with applicable regulations and good laboratory practice. Product information is educational and is not medical advice or evidence of efficacy.